CLDN5 and Alzheimer disease: This study indicates that NF-1 may contribute to reducing Aβ1-42-induced cellular aging and blood-brain barrier impairment in bEnd.3 cells and AD mice by potentially decreasing VEGF-R1 levels and supporting the expression of tight junction proteins ZO-1 and claudin-5.